
Sign up to save your podcasts
Or


Zak Mir talks to Ian Lankshear, CEO of EnSilica, about the leading fabless microchipmaker, which has announced that it has entered into two landmark development contracts with a leading European satellite operator to develop two chips for its next-generation satellite network.
EnSilica has been a listed company for 4 years, and after a period of steady groundwork, the business now appears to be entering a far more commercially significant phase. The key reason is simple: space communications is no longer a futuristic sideshow. It is becoming strategic infrastructure, and specialist chip design sits right at its heart.
That shift was underscored by EnSilica’s recent announcement that it has secured two landmark development contracts with a leading European satellite operator. The work covers two chips for a next-generation satellite network: one for the satellite's payload and one for the user terminal on the ground.
For a fabless semiconductor company, that is not just another contract win. It is the kind of milestone that can validate years of technical investment and establish a company as a serious supplier into a rapidly expanding global market.
Why 2026 could be a turning point for EnSilica
After four years on the market, EnSilica is now seeing several strands come together at once. The company has spent years building capability in semiconductor design, particularly in communications and high-performance, low-power applications. What is changing now is that the market is finally demanding exactly the kind of technology it has been developing.
The standout development is in the space sector. EnSilica has previously announced smaller wins, feasibility studies and early-stage projects, including work with AST SpaceMobile. But this latest contract with a European satellite operator looks more substantial. It signals that EnSilica is no longer simply participating in the sector. It is beginning to establish itself as a meaningful supplier within it.
The commercial logic is compelling. Satellite systems need chips that are:
Those requirements are technically demanding, which is precisely why they can create attractive opportunities for specialist chip designers with the right expertise and intellectual property.
Zak Mir talks to Dr Jim Millen, Non-Executive Chairman, Physiomics, regarding recent progress at the mathematical modelling, data science and biostatistics company, and issues regarding the forthcoming requisitioned meeting.
What Physiomics actually does
Physiomics is a specialised life sciences consultancy that works with companies developing new drugs. At its core, the business helps drug developers make better decisions about how they design and run studies.
The company operates across two main areas.
That combination matters. Drug development is expensive, time-consuming and high risk. The more rigorously a company can model likely outcomes and build trials correctly from a statistical standpoint, the better its chances of generating meaningful data and navigating the regulatory process successfully.
In simple terms, Physiomics is there to help clients ask the right questions before they spend serious money answering them.
Why mathematical modelling and biostatistics matter in drug development
It is worth pausing on this, because companies like Physiomics can easily be misunderstood as niche technical advisers operating in the background.
In reality, their work sits close to the heart of pharmaceutical decision-making. A poorly designed trial can waste years. A weak statistical framework can undermine otherwise promising results. And if preclinical and clinical plans are not thought through properly, the cost of fixing mistakes later can be enormous.
That is why the company’s two-pronged offering is significant:
For drug developers, especially in challenging therapeutic areas such as oncology, that expertise can be highly valuable.
Signs the business is turning a corner
One of the most important points to emerge recently is that Physiomics appears to be at a positive inflection point.
The company has reported its highest-ever first-half income, up by around 50% on the comparable prior period. Market expectations are also for the business to deliver its highest-ever full-year income, and management has indicated that it believes the company remains on track to achieve that.
That is not a trivial development. In a market where many life sciences businesses have struggled for funding and momentum, a services company tied to that ecosystem inevitably feels the pressure too.
The logic is straightforward:
By that measure, the last few years have not been easy. Management has been candid in saying that the wider life sciences market, especially over the past five years, has created a difficult backdrop. So when stronger income figures start to come through, that is naturally seen as evidence that the business may be emerging from a tougher period.
The phrase used was that the company feels like it is "turning a corner", and the recent numbers are being presented as proof of that shift.
The wider market backdrop for life sciences consultancies
To understand why recent progress matters, it helps to appreciate the commercial reality of a business like Physiomics.
This is not a company that develops and sells its own blockbuster drug. It provides highly specialised consultancy services to clients who are themselves trying to advance drug programmes. That means demand for Physiomics' expertise is linked to confidence, budgets and capital availability across the biotech and pharma landscape.
When funding conditions tighten, even capable drug developers may delay projects, reduce outsourced work or scale back trial activity. That can hit revenue visibility for service businesses, regardless of the quality of the service provided.
Against that backdrop, a strong first-half performance and confidence in a record year carry added significance. They suggest not just resilience, but possible operational momentum.
The share price has improved too, but that is not the whole story
Alongside the operational improvement, Physiomics' share price has also seen a notable rebound, rising by around 66% year to date at the time of discussion.
In ordinary circumstances, that would probably be taken as a clear signal that sentiment around the company is improving. But the picture is complicated by corporate governance developments, namely a requisition notice from activist shareholder Mike Whitlow.
That requisition has created a situation where improving business performance is happening at the same time as a challenge to the current board.
So while there may be genuine momentum in the underlying business, there is also uncertainty about who should be steering it.
What the requisition notice means
The requisition notice would, if passed, replace the current board with a new board.
Management’s position is clear: it does not believe that outcome would be in the best interests of the company.
The immediate practical consequence is that shareholders have been asked to vote at a general meeting. The chairman’s strongest message on this point is simple and democratic: shareholders should vote.
Whatever position an investor takes, the emphasis is on participation. This is being framed not as a routine procedural matter, but as a genuinely consequential decision about the company’s future direction and governance.
That is an important distinction. Boardroom disputes can sometimes appear remote or technical. Here, the argument is that the vote could materially affect how the company is run at a delicate stage in its development.
Why management says this is the wrong time to “rock the boat”
The timing is at the centre of the board’s response.
The current leadership’s view is that this challenge is arriving just as the company is beginning to show evidence of a turnaround. In other words, if the business is finally moving towards stronger revenue and a better trajectory, this may be precisely the wrong moment to disrupt leadership and strategy.
That argument rests on a few connected ideas:
The phrase “rock the boat” captures the concern neatly. A business that has spent years navigating a difficult market and is now seeing signs of recovery may not benefit from abrupt upheaval, particularly if the alternative leadership has not set out a clear and credible plan.
The board’s objections to the proposed replacement directors
Management’s opposition is not based only on timing. It has also raised several specific concerns about the individuals named in the requisition notice.
1. Lack of clearly relevant life sciences services experience
One criticism is that the proposed directors do not appear, from the current board’s perspective, to have the right experience in life sciences services.
That point matters because Physiomics operates in a specialist technical area. This is not a generic consultancy business. It works at the intersection of mathematical modelling, clinical development and biostatistics. Running such a company effectively may require sector-specific understanding, not just general boardroom experience.
2. No clear plan has been presented
Another issue is the lack of an articulated strategy.
The current board says it has seen no evidence of a plan, not even at a high level, explaining what the replacement board would actually do with the company.
That absence of detail is central to the concern. Replacing a board is one thing. Explaining the strategy that would follow is another. Without that second piece, shareholders are effectively being asked to back change without a roadmap.
3. Concerns about independence
The board has also highlighted governance concerns. Specifically, it says the proposed individuals are all connected parties in some way, either through previous or current working relationships.
From a governance standpoint, that raises the question of board independence. Best practice generally favours having independent directors who can challenge each other, think autonomously and avoid groupthink.
If all proposed appointees are closely connected, the argument is that this could weaken the balance and independence expected of a well-run board.
The central problem: shareholders are being asked to choose without enough detail
Perhaps the most striking concern is also the simplest one: nobody really knows what the incoming group would do if it took control.
That uncertainty sits at the heart of management’s case against the requisition. The issue is not merely whether change is good or bad in principle. It is whether shareholders should support a board replacement when the intended strategy has not been laid out.
As framed by the current leadership, that creates an asymmetrical choice:
From that perspective, the proposed change looks less like a defined alternative and more like a leap into the unknown.
That is really the essence of the argument.
Could the new group still have good intentions?
To be fair, the current board has not claimed that the requisitioning group intends to damage the company. In fact, the stated hope is that they are interested because they see real potential in Physiomics and want to continue building on the progress already made.
But hope is not the same as certainty.
Without a clearly stated strategy, the board’s position is that shareholders are being asked to make a consequential decision based on assumptions rather than evidence. And in a listed company, particularly one operating in a specialist and commercially sensitive field, that may not be enough.
What shareholders are being asked to do
The practical takeaway is very clear. Shareholders are being urged to participate in the vote at the general meeting.
The board’s formal recommendation is that the resolutions should be rejected. But beyond that recommendation, there is a broader appeal to engagement. This is being presented as one of those moments when shareholders can directly influence the direction of the company.
The message is not complicated:
In governance terms, that is the crux of it. A listed company only functions properly when shareholders take an active interest in major decisions, especially when those decisions concern leadership, strategy and accountability.
The bigger picture for Physiomics
Strip away the corporate drama, and the underlying story is a relatively straightforward one.
Physiomics is a specialist life sciences consultancy working in mathematical modelling and biostatistics for drug development. It has come through a difficult period for the wider life sciences sector and is now reporting stronger financial performance, with signs that it could deliver a record year.
At exactly that moment, it faces an activist-led attempt to replace the board.
Management’s view is that this is the wrong intervention at the wrong time. The company says it is making progress, the business environment is becoming more supportive, and a disruptive governance change without a clearly articulated alternative plan would introduce unnecessary risk.
Whether shareholders agree is, of course, a matter for them. But the issues at stake are now clear:
Those are not side issues. They go to the heart of whether Physiomics can build on its recent progress and sustain the upward trajectory management believes is now underway.
Zak Mir talks to Ignacio Mehech, CEO of CleanTech Lithium (AIM: CTL), regarding the milestones achieved by the exploration and development company advancing sustainable lithium projects in Chile.
The company recently announced an update on two trials being undertaken in North America and in Santiago, Chile, to produce battery-grade lithium carbonate from the Laguna Verde project. The trials focus on replicating and validating the process design defined in the Laguna Verde Pre-Feasibility Study.
Highlights:
· In North America, stage two of the downstream processing of eluate* (see footnote for definition) produced by our DLE pilot plant located in Chile, into battery grade lithium carbonate has commenced.
· The first stage of this work was undertaken by Conductive Energy and reported to the market in January 2025.
· Conductive Energy was acquired by Empower EIT over the course of 2025, with Empower establishing an advanced lithium processing facility in Dallas, USA.
· This second stage of eluate conversion will process >60m3 of concentrated eluate at the new facility.
· The nanofiltration stage of the process will utilise an advanced membrane developed by DuPont Water Solutions to maximise impurity removal and lithium recovery.
· Approximately 300kg of battery grade lithium carbonate are expected to be produced in Q2 2026 and made available to potential strategic partners for product qualification.
· Concurrently, a smaller scale pilot programme is underway utilising the pilot plant of Lanshen Technology ("Lanshen"), located in Santiago, Chile.
· This pilot plant replicates the process flowsheet developed with Lanshen for the Laguna Verde PFS and aims to demonstrate the robustness of the process design and provide a high degree of validation of the process parameters used in the PFS.
· A volume of 24m3 of feed brine from Laguna Verde is being processed into >5kg of battery grade lithium carbonate.
Ignacio Mehech, Chief Executive Officer, CleanTech Lithium said: "We are undertaking important pilot scale process trials in North America and Chile to produce battery grade lithium carbonate from Laguna Verde brine. This work will provide strong technical support for the process flow sheet used in our PFS which we think is an important consideration for engaging with potential strategic investors."
Zak Mir talks to Sath Ganesarajah, CEO of Bluebird Mining Ventures Ltd (BMV), as the gold streaming, mining and treasury company confirmed that Frank Amato and Hernán M. Yellati have been appointed to the Board as Non-Executive Directors with immediate effect.
Frank Amato will serve as Chair of the Audit Committee, while Hernán M. Yellati has been appointed Chair of the Remuneration and Nomination Committee.
Bluebird Mining Ventures Ltd has strengthened its board with the appointment of Frank Amato and Hernán M. Yellati as Non-Executive Directors, in a move aimed at enhancing governance and strategic oversight.
Amato will also serve as Chair of the Audit Committee, while Yellati takes on the role of Chair of the Remuneration and Nomination Committee.
In addition, Board Advisors Darron Giddens and John Webb will participate in Audit Committee meetings, with Webb also appointed to chair a newly established Conflicts Committee.
The changes are designed to bolster the company’s governance framework as it continues to execute its growth strategy.
Sath Ganesarajah, Chief Executive Officer of BMV, said: "We are delighted to formally welcome Frank and Hernán to the Board. They bring significant experience across financial markets, macroeconomic strategy and emerging technologies, which will be invaluable as we continue to execute our growth strategy.
"I look forward to working closely with them and our Advisory Board to further strengthen governance, enhance strategic oversight and drive the business forward. Their leadership of the Audit Committee and the Remuneration and Nomination Committee respectively will play an important role in supporting the Company's long-term objectives and delivering value for shareholders."
About Bluebird Mining Ventures Ltd
Bluebird Mining Ventures (LSE: BMV) is a gold streaming, mining and treasury company. The Company's mission is to build and manage a gold-backed treasury through streaming agreements, providing investors with exposure to physical gold without the operational risk of mining.
BMV focuses on streams from producing assets within the ore concentrate to bullion value chain. Its investments secure multi-year flows of gold that can be recycled into new transactions. This model enables scalable exposure to gold without capital expenditure, or execution risks.
Drawing on its heritage in gold, BMV combines the stability of physical bullion with the benefits of a scalable, disciplined business model. With a focus on prudent capital allocation and treasury management, BMV aims to deliver sustainable, long-term value for shareholders.
For more information, please visit: www.bmvbtc.com
Zak Mir talks to Alexander Selegenev, Executive Director, TMT Investments, in the wake of the venture capital company investing in high-growth technology companies, announcing its audited final results for the year ended 31 December 2025.
TMT Investments PLC has reported a strong set of audited results for 2025, marked by a return to profitability and growth in asset value.
Net Asset Value (NAV) per share increased to $7.13, up from $6.55 the previous year, with total NAV rising to $220.8 million.
The company delivered a profit of $16.6 million, a significant turnaround from a $2.2 million loss in 2024, supported in part by gains from investments, including a notable uplift from its stake in Scale AI.
Investment activity slowed during the year, with $1.5 million deployed compared to $5.9 million in 2024, while $5.5 million was realised through disposals and dividends.
TMT also completed a $1.7 million share buyback programme, and ended the year with $5.0 million in cash, maintaining liquidity for future opportunities.
Alexander Selegenev, Executive Director of TMT, commented:
"In 2025, TMT's net asset value increased 8.9%, mainly as a result of the significant positive currency exchange impact on the Company's Pound Sterling and Euro-denominated investments and the continued growth of TMT's investment in Scentbird. This was a period of continuing macroeconomic and political instability, as well as of subdued venture capital, IPO, and M&A activity outside the AI segment.
TMT's portfolio benefited from positive revaluations of seven of its investee companies (Bolt, Scentbird, Global Work AI, Spin.ai, Scale AI, Rhino, and Whizz), which have been partly offset by full and partial write-downs in the value of nine of the Company's investments (Backblaze, Mobilo, SOAX, MTL Financial, Prodly, Sonic Jobs, Aurabeat, Qumata, and Go X), in line with TMT's highly prudent valuation approach.
The majority of TMT's portfolio companies continue to demonstrate good business progress and have adapted well to the challenges of the current environment. Despite reduced revenue growth rates for some investees in this environment, many of them have managed to reach either profitability or positive operating cash flow levels.
TMT successfully disposed of partial stakes in some of its portfolio companies (most notably, Backblaze and Bolt) at NAV-enhancing valuation levels.
Given the continued high level of market uncertainty and volatility in 2025, TMT maintained its cautious investment approach during the period, and made only four new and follow-on investments. Two new companies were added to TMT's portfolio, Spendbase Inc. and Leasy Holdings Limited.
In 2025, TMT's shares often traded at a 60%+ discount to NAV, and at this valuation it was hard for management to identify a better investment opportunity than TMT's current investment portfolio itself. Accordingly, the Company successfully completed a share buyback programme, in which a total of 651,688 TMT shares were bought at a weighted average price of US$2.65 per share for a total consideration of US$1,729,657.
With no financial debt and strong cash reserves, TMT is well positioned to not only ride out the current market volatility, but also to continue making investments and realising full and partial disposals when the right opportunities present themselves.
We look forward to keeping shareholders updated on relevant developments in due course."
Zak Mir talks to Howard White, Chairman Hydrogen Utopia, in the wake of a report in the Financial Times, regarding airlines scrambling to source aviation fuel.
Hydrogen Utopia and the “all bases are loaded” case for sustainable aviation fuelAirlines do not just worry about fares and demand. They worry about fuel. And when geopolitical tensions flare up, contingency planning starts quickly, including new approaches to aviation fuel supply.
That is the context Howard White, Chairman of Hydrogen Utopia, uses to frame today’s opportunity: rather than treating sustainable aviation fuel (SAF) as a niche ideal, he argues it should be treated as a practical, supply-secure alternative that can withstand disruption.
Why airline fuel shortages matter more than you think
Recent reporting has highlighted how airlines can be hit hard by fuel shortages and price shocks tied to geopolitical events. The headlines are blunt: airlines draw up contingency plans when jet fuel supply becomes uncertain, and disruptions can translate into very large financial impacts.
The underlying lesson is simple. When supply chains rely too heavily on a narrow set of locations and traditional production routes, the entire system becomes more fragile. In that environment, “strategy” is not a slogan. It is a risk management requirement.
The SAF problem: “great idea,” but can it compete on price and supply?
White’s view is that many conversations about SAF stall at a single question: can it reach parity with the price of conventional jet fuel?
He references a point made by a head of a major airline in discussions prior to the current crisis: SAF is welcome, but it needs to “get to par” with jet A1 pricing.
White positions Hydrogen Utopia’s approach as a direct response to that pricing pressure. He describes a SAF cost around $200 versus jet A1 at roughly $175 at the time of his comments, suggesting the “parity” goal is closer than many assume.
“All bases are loaded”: a contra perspective on where Hydrogen Utopia is positioned
White describes the market as myopic. In his framing, people see Saudi Arabia and immediately assume that everything becomes risky. His counterpoint is that the region is unlikely to disappear, and the strategic need for resilient fuel supply and internal investment only increases under stress.
He also reframes the location question. Traditional SAF pathways often require facilities and supply chains that are vulnerable to targeted disruptions. He argues Hydrogen Utopia’s model is more flexible because it is modular and can be deployed in safer jurisdictions.
Waste plastic as a feedstock: solving two problems at once
One of the most compelling parts of the argument is feedstock availability. White’s case rests on the idea that the company does not rely on a natural resource supply chain like oil or gas.
Instead, he points to mixed waste plastic, including unrecyclable plastic, as a “ubiquitous” input across the Middle East and North Africa (MENA) region. In other words: if waste plastic exists everywhere (because it is produced everywhere and often not properly managed), then production can follow demand without being trapped in one geopolitical footprint.
He adds a blunt economic twist: in most countries, authorities may even pay for solutions that remove plastic waste. Hydrogen Utopia, he says, is “not going to be paying for the plastic.” That can convert waste management into a supportive revenue stream rather than a cost centre.
Hydrogen at $2 a kilo: opening doors beyond SAF
SAF is the headline, but White argues the technology unlocks additional markets by producing hydrogen internally at a very low stated cost: $2 per kilo.
He ties this to more than one downstream opportunity:
He also gives a real-world example of supply pressure: Brazil being extremely short of urea due to logistics constraints. In his logic, if hydrogen is competitive, then fertiliser production becomes more scalable and less tied to the same geopolitical vulnerabilities.
Why the timing could be faster than investors expect
In technology markets, delays kill momentum. White pushes back on the typical “wait 2 or 3 years” expectation for development milestones.
He highlights a proposed $800 million project being evaluated for funding and moving toward FID (Final Investment Decision), with Saudi Arabia timelines suggesting movement within up to 15 months.
He also references the creation of a Saudi Arabia subsidiary, which he says can be used as a base for funding and execution in the region. The implication is that the company is not just discussing future potential. It is building the administrative and commercial pathway to scale.
Regulatory and commercial momentum: more than one country is looking
White points to ongoing engagement across the GCC during the Ramadan period, describing the process as active rather than slow.
He mentions discussions and communications involving countries including:
He also notes that one UAE-based company that deploys technologies across the region has begun due diligence to assess whether it should take a major involvement in SAF and other opportunities within the GCC.
What partnerships and monetisation could look like
The next stage, according to White, is not technology validation. It is monetisation: turning interest into financing, contracting, and commercial delivery.
He frames the “game” as one where money becomes available once projects are sufficiently underwritten and funded, and he indicates that this is the direction of travel after a period of embedded regional work and corporate validation through public announcements.
The bottom line: diversification that is strategic, scalable, and disruption-resistant
White’s core thesis is that the current climate is reinforcing a shift in thinking:
In his closing sentiment, White suggests that the situation does not reduce opportunity. It increases it. One catalyst event, he implies, could accelerate the next phase of funding and momentum.
For investors watching sustainable fuels, the question becomes less “is SAF needed?” and more “who can deliver it at scale, in the right places, with resilient supply and credible economics?” Hydrogen Utopia’s pitch is essentially that it has a modular route to get there.
Zak Mir talks to Paul Emmitt, CEO of Powerhouse Energy, about recent progress at the company, including its pioneering integrated technology that converts non-recyclable waste into low-carbon energy, and its revenue-generating engineering consulting division. They discuss PHE's proven technology, its projects and newsflow drivers.
Powerhouse Energy: Turning Non‑Recyclable Waste into Low‑Carbon Energy
Powerhouse Energy is positioning itself where two urgent problems intersect: mounting non‑recyclable waste and the need to decarbonise industrial energy. The company has developed an integrated waste‑to‑energy solution that converts difficult waste streams into useful products — syngas, hydrogen or power — using a robust, proven process based on a rotating kiln.
What Powerhouse Energy offers
At its core, Powerhouse Energy provides a technology platform and engineering capability that turns problematic waste into real value. Rather than competing with recycling, it tackles the residual fraction that typically goes to landfill or is incinerated.
Key outcomes the company targets:
How the technology works — simple and proven
Powerhouse Energy’s process is a gasification system built around a rotating kiln. That configuration brings two advantages:
The downstream equipment—gas cleanup, conditioning and conversion units—uses established industrial technology, which lowers technical risk for potential customers and investors.
The Feedstock Testing Unit: the turning point
One of the most important recent milestones was the completion of a feedstock testing unit (FTU) at the company’s Brandon site in March last year. The FTU serves several crucial purposes:
As the CEO put it succinctly:
"The technology is here for people to see and see work."
Commercialisation pathway and project landscape
Powerhouse Energy is working across several geographies and project types, from licensing and royalties to design‑build‑operate models where it retains control of delivery.
Current project highlights and opportunities include:
Importantly, many enquiries are becoming tangible opportunities: in the past 12 months the company received roughly 50–60 enquiries and has around a dozen genuine opportunities under discussion. That pipeline is a positive signal of market interest.
Why market valuation lags — and what will change it
Powerhouse Energy’s market capitalisation sits around £15 million, while the global waste‑to‑energy market runs into the billions. That gap reflects the typical early‑stage dynamic: technology proven at demonstration scale must cross the commercial threshold before valuations re‑rate.
The decisive inflection point will be a signed contract for the first commercial unit. That could be:
Obtaining a first commercial order validates technology, starts revenue recognition and reduces perceived risk for future customers and investors. The company is open to creative commercial structures to overcome the "nobody wants to be first" problem, including moving or deploying the FTU to a partner site as a demonstration of commerciality.
What to watch next
For anyone tracking the company, the next major newsflow drivers are clear:
Where Powerhouse Energy sits in the energy transition
There is sometimes a binary narrative that only electrification and “100% renewable” solutions are green. In practice, the waste problem persists and requires pragmatic, low‑carbon solutions. Powerhouse Energy is not positioned as a replacement for recycling but as a complementary pathway: it deals with materials that would otherwise be landfilled or poorly controlled incinerated.
By turning that residual waste into syngas or hydrogen, the company helps organisations meet waste management targets, reduce fossil fuel dependence for site power and advance decarbonisation strategies in industries where waste remains an intractable problem.
Summary
Powerhouse Energy has moved from concept to demonstrable technology. With a functioning feedstock testing unit, a growing pipeline of enquiries and concrete projects under discussion, the company’s next milestone is commercial traction — a signed first unit. When that happens, it will mark the transition from technology validation to revenue generation and should materially change market perception.
For organisations wrestling with non‑recyclable waste and industrial decarbonisation, Powerhouse Energy offers a pragmatic, proven route to convert waste into useful, low‑carbon energy streams.
We caught up with Sam Garrett, Chief Executive Officer of Great Southern Copper (LON: GSCU), this week after the company announced the partial assay results of Hole CNG25-DD042 (DD042) recently received for its Phase III drilling programme at the Cerro Negro prospect, part of the Especularita Project.
Highlights:
· Hole CNG25-DD042 tested the interpreted southern extension of Lens 2 some 300m along trend from the Mostaza mine
· The hole intersected multiple zones or lenses of base and precious metals mineralisation including significant intercepts
· An upper Pb-Zn-Ag rich silica breccia zone includes grades up to 22.4g/t Ag, 1.9% Pb and 0.34% Zn similar to the mineralisation identified in the hanging-wall to Lens 2
· DD-042 results extends the Mostaza system to over 400m of strike length with mineralisation open to the south
· Pb and Zn rich intervals add further evidence of a complex multiphase stacked system
· Results pending for final diamond holes and all RC drill holes
· Planning for fully funded Phase IV resource and exploration drilling is in progress
· GSC holds option to 100% of the Cerro Negro project including the Mostaza mine
· Project located at low elevation with excellent access to mining-related infrastructure
Sam Garrett, Chief Executive Officer of Great Southern Copper, said: “These latest results for step-out hole DD042 continue to demonstrate the strong growth potential of the Mostaza copper-silver discovery. Intersecting mineralisation at this distance from the historic workings provides further evidence that the Mostaza Fault Zone hosts a much broader mineralised footprint than originally recognised and emphasises the significant exploration upside still to be tested along this emerging trend.
“Importantly, the presence of significant Pb and Zn mineralisation in DD042 within an upper silica-sulphide breccia zone underlain by high-grade chalcocite-clay mineralisation is consistent with the deposit architecture recognised below the Mostaza mine, reinforcing the exciting proposition that this represents a potential extension of the Mostaza Lens 2 trend towards the south.
“Exploration work to date has already traced mineralisation and alteration signatures for over two kilometres of the Mostaza Fault Zone, and this latest step-out hole is another important confirmation that the system remains open and continues to grow.
“Planning for our fully funded Phase IV drilling campaign is underway and will focus on in-fill drilling of Lens 2 between the Mostaza mine and the mineralisation intersected in holes DD07 and DD042, as well as additional step-out drilling aimed to extend the Lens 2 mineralisation trend further south along the Mostaza Fault Zone. In addition, we look forward to continuing to test the broader potential of the Cerro Negro system.”
The Extrakt technology: cleaner, simpler, scalable
Fulcrum has partnered with a proprietary process referred to as Extrakt. The core claims are simple but powerful: a single process that is zero cyanide and zero waste, capable of recovering gold alongside valuable co‑products such as tellurium, gallium and silver.
Early bench testing delivered initial gold recoveries around 59%. More recent Phase 3 testwork has produced results in excess of 70% for both gold and silver, with further optimisation underway. In addition, extended leach testing is targeting critical minerals such as tellurium and gallium — potentially transforming the economics by increasing the project’s gold‑equivalent grade.
Phase 3 and the rise of co‑products
Phase 3 is the pivotal study for Fulcrum. The company has already flagged preliminary Phase 3 results and expects further announcements in the near term. Key takeaways:
Market response and share register dynamics
The market has noticed the progress. Share price momentum pushed the company near one‑year highs and produced notable insider and institutional activity. Several TR1 filings showed increases from investors including Metals One, Nick Nugent and Ian Bagnell, amounting to just over 26% combined. Directors retain roughly 19% of the register, tightening ownership and aligning incentives.
At the time of reporting, the stock was up about 30.51% year‑to‑date, with a market capitalisation of around £11.09m. That performance suggests growing investor appetite for technology‑driven, lower‑impact resource plays.
Valuation perspective and upside potential
The company’s projects host an estimated 200,000 ounces of gold. Using a bullish gold price reference quoted by management (~US$5,000/oz at the time), the in‑situ metal value can look large on paper. That said, there are important caveats:
In short: the combination of a credible resource base plus a potentially disruptive extraction method creates meaningful upside if the technology scales and regulatory, permitting and commercial hurdles are cleared.
What to watch next
Bottom line
Fulcrum Metals is positioning itself as more than a gold explorer. By combining tailings assets with a zero‑cyanide extraction method and the prospect of multiple recoverable metals, the company is aiming to offer a cleaner, faster route to value. The next tranche of Phase 3 results and any pilot‑scale confirmations will be the most important value inflection points to watch.